Novel quinazoline and acetamide derivatives as safe anti-ulcerogenic agent and anti-ulcerative colitis activity

Two novel quinazoline derivatives named as; 3-[(4-hydroxy-3-methoxy-benzylidene)-amino]-2-p-tolyl-3H-quinazolin-4-one (5) and 2-p-Tolyl-3-[3,4,5-trimethoxy-benzylidene-amino]-3H-quinazolin-4-one (6) in addition to one acetamide derivative named as 2-(2-Hydroxycarbonylphenylamino)-N-(4-aminosulphonyl...

Full description

Bibliographic Details
Main Authors: Fatmah A.S. Alasmary, Amani S. Awaad, Ahmed M. Alafeefy, Reham M. El-Meligy, Saleh I. Alqasoumi
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Saudi Pharmaceutical Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016417301676
_version_ 1819179847455342592
author Fatmah A.S. Alasmary
Amani S. Awaad
Ahmed M. Alafeefy
Reham M. El-Meligy
Saleh I. Alqasoumi
author_facet Fatmah A.S. Alasmary
Amani S. Awaad
Ahmed M. Alafeefy
Reham M. El-Meligy
Saleh I. Alqasoumi
author_sort Fatmah A.S. Alasmary
collection DOAJ
description Two novel quinazoline derivatives named as; 3-[(4-hydroxy-3-methoxy-benzylidene)-amino]-2-p-tolyl-3H-quinazolin-4-one (5) and 2-p-Tolyl-3-[3,4,5-trimethoxy-benzylidene-amino]-3H-quinazolin-4-one (6) in addition to one acetamide derivative named as 2-(2-Hydroxycarbonylphenylamino)-N-(4-aminosulphonylphenyl) 11 were synthesized, and evaluated for their anti-ulcerogenic & Anti-Ulcerative colitis activities.All of the three compounds showed curative activity against acetic acid induced ulcer model at a dose of 50 mg/kg, they produced 65%, 85% & 57.74% curative ratio for compounds 5, 6 & 11 respectively. The effect of the tested compounds 5, 6 & 11 at dose 50 mg/kg were significantly (P < 0.01) more effective than dexamesathone (0.1 mg/kg) in reducing all parameters.Compounds showed curative activity of for peptic ulcer (induced by absolute alcohol (at a dose of 50 mg/kg, it produced Curative of control ulcer 56.00%, 61.70% & 87.1% for compounds 5, 6 & 11 respectively at dose 50 mg/kg, while the standard drug (Omeprazole 20 mg/kg) produced 33.3%. In both tests, the activity of our target compounds were higher than the standard drugs used for treatment of peptic ulcer and ulcerative colitis. No side effects were reported on liver and kidney functions upon prolonged oral administration of this compounds. Keywords: Liver functions, Ulcers, Dexamesathone, Quinazoline, Acetamide, Ulcerative colitis
first_indexed 2024-12-22T22:04:57Z
format Article
id doaj.art-aafb917dd5fd413d9516033ad565f6aa
institution Directory Open Access Journal
issn 1319-0164
language English
last_indexed 2024-12-22T22:04:57Z
publishDate 2018-01-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj.art-aafb917dd5fd413d9516033ad565f6aa2022-12-21T18:11:00ZengElsevierSaudi Pharmaceutical Journal1319-01642018-01-01261138143Novel quinazoline and acetamide derivatives as safe anti-ulcerogenic agent and anti-ulcerative colitis activityFatmah A.S. Alasmary0Amani S. Awaad1Ahmed M. Alafeefy2Reham M. El-Meligy3Saleh I. Alqasoumi4Chemistry Department, College of Science, King Saud University, Riyadh 11362, Saudi ArabiaPharmacognosy Department, College of Pharmacy, Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia; Corresponding author at: Pharmacognosy Department, College of Pharmacy, Prince Sattam bin Abdulaziz University, P.O. Box 173, Al-Kharj, Riyadh 11942, Saudi Arabia.Department of Chemistry, Kulliyyah of Science, International Islamic University Malaysia, MalaysiaAromatic and Medicinal Plants Department, Desert Research Center, Cairo, EgyptDepartment of Pharmacognosy, College of Pharmacy, King Saud University, KSATwo novel quinazoline derivatives named as; 3-[(4-hydroxy-3-methoxy-benzylidene)-amino]-2-p-tolyl-3H-quinazolin-4-one (5) and 2-p-Tolyl-3-[3,4,5-trimethoxy-benzylidene-amino]-3H-quinazolin-4-one (6) in addition to one acetamide derivative named as 2-(2-Hydroxycarbonylphenylamino)-N-(4-aminosulphonylphenyl) 11 were synthesized, and evaluated for their anti-ulcerogenic & Anti-Ulcerative colitis activities.All of the three compounds showed curative activity against acetic acid induced ulcer model at a dose of 50 mg/kg, they produced 65%, 85% & 57.74% curative ratio for compounds 5, 6 & 11 respectively. The effect of the tested compounds 5, 6 & 11 at dose 50 mg/kg were significantly (P < 0.01) more effective than dexamesathone (0.1 mg/kg) in reducing all parameters.Compounds showed curative activity of for peptic ulcer (induced by absolute alcohol (at a dose of 50 mg/kg, it produced Curative of control ulcer 56.00%, 61.70% & 87.1% for compounds 5, 6 & 11 respectively at dose 50 mg/kg, while the standard drug (Omeprazole 20 mg/kg) produced 33.3%. In both tests, the activity of our target compounds were higher than the standard drugs used for treatment of peptic ulcer and ulcerative colitis. No side effects were reported on liver and kidney functions upon prolonged oral administration of this compounds. Keywords: Liver functions, Ulcers, Dexamesathone, Quinazoline, Acetamide, Ulcerative colitishttp://www.sciencedirect.com/science/article/pii/S1319016417301676
spellingShingle Fatmah A.S. Alasmary
Amani S. Awaad
Ahmed M. Alafeefy
Reham M. El-Meligy
Saleh I. Alqasoumi
Novel quinazoline and acetamide derivatives as safe anti-ulcerogenic agent and anti-ulcerative colitis activity
Saudi Pharmaceutical Journal
title Novel quinazoline and acetamide derivatives as safe anti-ulcerogenic agent and anti-ulcerative colitis activity
title_full Novel quinazoline and acetamide derivatives as safe anti-ulcerogenic agent and anti-ulcerative colitis activity
title_fullStr Novel quinazoline and acetamide derivatives as safe anti-ulcerogenic agent and anti-ulcerative colitis activity
title_full_unstemmed Novel quinazoline and acetamide derivatives as safe anti-ulcerogenic agent and anti-ulcerative colitis activity
title_short Novel quinazoline and acetamide derivatives as safe anti-ulcerogenic agent and anti-ulcerative colitis activity
title_sort novel quinazoline and acetamide derivatives as safe anti ulcerogenic agent and anti ulcerative colitis activity
url http://www.sciencedirect.com/science/article/pii/S1319016417301676
work_keys_str_mv AT fatmahasalasmary novelquinazolineandacetamidederivativesassafeantiulcerogenicagentandantiulcerativecolitisactivity
AT amanisawaad novelquinazolineandacetamidederivativesassafeantiulcerogenicagentandantiulcerativecolitisactivity
AT ahmedmalafeefy novelquinazolineandacetamidederivativesassafeantiulcerogenicagentandantiulcerativecolitisactivity
AT rehammelmeligy novelquinazolineandacetamidederivativesassafeantiulcerogenicagentandantiulcerativecolitisactivity
AT salehialqasoumi novelquinazolineandacetamidederivativesassafeantiulcerogenicagentandantiulcerativecolitisactivity